Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The use of automation in DOE can streamline execution and accelerate process development.
March 11, 2024
By: Caroline McCormack
Process Scientist, Innopharma Research Ltd.
The trend towards continuous manufacturing (CM) in the pharmaceutical industry continues to grow for a multitude of reasons which include, a small footprint and the ability to scale-out rather than scale-up as the duration of a manufacturing campaign is simply extended to meet commercial needs. Modular CM platforms provide the ability to quickly switch between unit operations for on-demand production, offer less material waste associated with process deviations, and have the ability to rapidly perform Design of Experiments (DOE).1,2 Continuous manufacturing has the potential to accelerate drug production and improve global supply issues and has gained strong support from regulatory bodies such as the U.S. FDA.1,3,6 Automation is front and center in implementing any continuous process/manufacturing line and is built on a foundation of in-depth process knowledge and understanding. DOE is one of the first steps in the process development cycle to acquire more thorough understanding of the design space and in defining the key relationships between important process variables and material quality attributes.4 DOEs can have a reputation to be laborsome, particularly when executed manually. Automating the DOE process can save on valuable time and resources by enabling more precise experimentation and rapid data generation. This ultimately leads to accelerated process development and drives process understanding, thereby resulting in a more robust process. This paper presents an example of the utility and flexibility afforded when applying automation to DOE in twin screw wet granulation (TSWG), in support of accelerated process development by managing more effectively the intricacies associated with executing more complex DOE variables, that would otherwise be more challenging to implement manually. Automation is implemented through SmartX, a process digitalization and automation platform developed by Innopharma Technology. It should be noted that the automated DOE approach described here is also broadly applicable to hot melt extrusion or any other type of twin screw-based process.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !